186 related articles for article (PubMed ID: 37498463)
1. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
Iyer P; Gao Y; Jalal D; Girotra S; Singh N; Vaughan-Sarrazin M
Clin Rheumatol; 2024 Jan; 43(1):87-94. PubMed ID: 37498463
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis.
Cordova Sanchez A; Khokhar F; Olonoff DA; Carhart RL
Cardiovasc Drugs Ther; 2024 Apr; 38(2):297-304. PubMed ID: 36197529
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
D'Andrea E; Desai RJ; He M; Glynn RJ; Lee H; Weinblatt ME; Kim SC
J Am Coll Cardiol; 2022 Jul; 80(1):36-46. PubMed ID: 35772915
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
[TBL] [Abstract][Full Text] [Related]
5. Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study.
Hoque MR; Lu L; Daftarian N; Esdaile JM; Xie H; Aviña-Zubieta JA
Arthritis Rheumatol; 2023 Mar; 75(3):475-484. PubMed ID: 36054570
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
Faselis C; Zeng-Treitler Q; Cheng Y; Kerr GS; Nashel DJ; Liappis AP; Weintrob AC; Karasik PE; Arundel C; Boehm D; Heimall MS; Connell LB; Taub DD; Shao Y; Redd DF; Sheriff HM; Zhang S; Fletcher RD; Fonarow GC; Moore HJ; Ahmed A
Arthritis Rheumatol; 2021 Sep; 73(9):1589-1600. PubMed ID: 33973403
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine had neutral effect on long-term risk of malignancy in rheumatoid arthritis patients: A population-based retrospective cohort study.
Hou XJ; Chang R; Wang YH; Kang TL; Wei JC
Int J Rheum Dis; 2024 Mar; 27(3):e15102. PubMed ID: 38450839
[TBL] [Abstract][Full Text] [Related]
9. Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
Lane JCE; Weaver J; Kostka K; Duarte-Salles T; Abrahao MTF; Alghoul H; Alser O; Alshammari TM; Areia C; Biedermann P; Banda JM; Burn E; Casajust P; Fister K; Hardin J; Hester L; Hripcsak G; Kaas-Hansen BS; Khosla S; Kolovos S; Lynch KE; Makadia R; Mehta PP; Morales DR; Morgan-Stewart H; Mosseveld M; Newby D; Nyberg F; Ostropolets A; Woong Park R; Prats-Uribe A; Rao GA; Reich C; Rijnbeek P; Sena AG; Shoaibi A; Spotnitz M; Subbian V; Suchard MA; Vizcaya D; Wen H; Wilde M; Xie J; You SC; Zhang L; Lovestone S; Ryan P; Prieto-Alhambra D;
Rheumatology (Oxford); 2021 Jul; 60(7):3222-3234. PubMed ID: 33367863
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Jorge A; Lu N; Choi H; Esdaile JM; Lacaille D; Avina-Zubieta JA
Arthritis Care Res (Hoboken); 2023 Apr; 75(4):743-748. PubMed ID: 34941008
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
Front Immunol; 2021; 12():631869. PubMed ID: 33868251
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
Ann Rheum Dis; 2018 Jan; 77(1):98-103. PubMed ID: 28970215
[TBL] [Abstract][Full Text] [Related]
13. Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019.
Kim JW; Kwak SG; Lee H; Kim SK; Choe JY; Park SH
Korean J Intern Med; 2022 May; 37(3):673-680. PubMed ID: 33706472
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort study.
He M; Pawar A; Desai RJ; Glynn RJ; Lee H; Weinblatt ME; Solomon DH; Kim SC
Semin Arthritis Rheum; 2021 Dec; 51(6):1242-1250. PubMed ID: 34757241
[TBL] [Abstract][Full Text] [Related]
15. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
[TBL] [Abstract][Full Text] [Related]
16. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
[TBL] [Abstract][Full Text] [Related]
18. Use of Hydroxychloroquine and Risk of Heart Failure in Patients With Rheumatoid Arthritis.
Sorour AA; Kurmann RD; Shahin YE; Crowson CS; Achenbach SJ; Mankad R; Myasoedova E
J Rheumatol; 2021 Oct; 48(10):1508-1511. PubMed ID: 33452171
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
Meng H; Lam SH; So H; Tam LS
Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
